Search filters

List of works by Ronald van Vollenhoven

2016 update of the EULAR recommendations for the management of early arthritis ⬇️

scientific article published on 15 December 2016

2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis

scientific article published on 27 March 2020

25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort

scientific article

A Comparison of 2019 EULAR/ACR SLE Classification Criteria with Two Sets of Earlier SLE Classification Criteria

scientific article published on 20 May 2020

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis

scientific article published on 25 April 2016

A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis ⬇️

scientific article published on 30 June 2017

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).

scientific article published on 24 November 2016

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission

scientific article

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

scientific article

Accrual of atherosclerotic vascular events in a multicentre inception SLE cohort

scientific article published on 09 June 2020

Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort

scientific article

Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone

scientific article published on 26 September 2017

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial ⬇️

scientific article published on November 29, 2012

Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial

scientific article

Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial

scientific article published on 01 March 2003

American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort

scientific article published in April 2014

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

scholarly article by J Askling et al published 1 May 2009 in Annals of the Rheumatic Diseases

Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis

scientific article

Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides

scientific article

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

scientific article published in 2022

Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort

scientific article published on 12 June 2019

Are dietary vitamin D, omega-3 fatty acids and folate associated with treatment results in patients with early rheumatoid arthritis? Data from a Swedish population-based prospective study

scientific article

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial

scientific article published on March 2016

Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate ⬇️

scientific article published on August 22, 2012

Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study

scientific article

Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus

scientific article

Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials

scientific article

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

scientific article

Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study

scientific article

Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial

scientific article published on August 2013

Biologicals for the treatment of systemic lupus erythematosus?

scientific article published on 15 April 2011

Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion

scientific article published on 20 July 2015

CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease

scientific article

CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients

scientific article

Cancer risk in a large inception SLE cohort: Effects of demographics, smoking, and medications

scientific article published on 19 August 2020

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

scientific article published in November 2009

Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort

scientific article published on 12 April 2016

Cerebrovascular Events in Systemic Lupus Erythematosus

scientific article published on 5 January 2018

Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III st ⬇️

scientific article published on 10 May 2016

Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients

scientific article

Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial

scientific article

Challenges and opportunities in SLE clinical trials ⬇️

scientific article published on September 1, 2013

Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus

scientific article published in September 2014

Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib

scientific article published on 01 October 2020

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial

scientific article published on 30 December 2014

Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol

article

Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis

scientific article published on 18 December 2007

Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts

scientific article

Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort

scientific article

Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC study

article

Clinical response to belimumab in academic clinical practices

scientific article published on 18 September 2014

Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry

scientific article

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease

scientific article

Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the Ameri

scientific article published on 13 March 2018

Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the Americ

scientific article published on 10 March 2018

Construction of a Frailty Index as a Novel Health Measure in Systemic Lupus Erythematosus

scientific article published on 15 April 2019

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

scientific article published on 29 March 2012

Cost-effectiveness of real-world infliximab use in patients with rheumatoid arthritis in Sweden

scientific article published in January 2010

Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials

scientific article published on 18 March 2016

Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial

scientific article published on 4 April 2014

Decreased live births in women with systemic lupus erythematosus

scientific article published on July 2011

Dehydroepiandrosterone for the treatment of systemic lupus erythematosus ⬇️

scientific article published on January 1, 2002

Dehydroepiandrosterone versus placebo for Sjögren's syndrome: comment on the article by Pillemer et al.

scientific article published in August 2005

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

scientific article published on August 2012

Diagnostic utility of musculoskeletal ultrasound in patients with suspected arthritis--a probabilistic approach

scientific article

Dietary Intake of Polyunsaturated Fatty Acids and Pain in spite of Inflammatory Control among Methotrexate Treated Early Rheumatoid Arthritis Patients

scientific article

Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: Results from the trial of etanercept and methotrexate with radiographic and patient outcomes

article

Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus

scientific article published on 7 April 2010

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial

scientific article

Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort

scientific article published on 08 February 2017

Does disease activity at the start of biologic therapy influence health care costs in patients with RA?

scientific article published on 21 March 2015

Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study

scientific article

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity

scientific article

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints

scientific article published on 23 April 2008

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

scientific article

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

scientific article published on 6 March 2017

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

scientific article published on 22 January 2020

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

scientific article

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

scientific article

Early start and stop of biologics: has the time come?

scientific article

Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists

scientific article published on 17 May 2016

Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach

scientific article published on 14 October 2019

Economic evaluation of lupus nephritis in the Systemic Lupus International Collaborating Clinics inception cohort using a multistate model approach

scientific article published on 28 November 2017

Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis

scientific article

Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials

scientific article

Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register

scientific article published on 15 January 2014

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

scientific article published on 4 October 2011

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

scientific article published on 15 September 2015

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

scientific article

Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controll

scientific article published on 20 August 2015

Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind stud

scientific article

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

scientific article published on 10 March 2017

Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis

scientific article published on 29 March 2017

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis

scientific article published on 26 July 2016

Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

scientific article published on 20 June 2016

Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious

scientific article

Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus

scientific article published on 29 May 2019

Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial ⬇️

scientific article published on March 5, 2013

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update ⬇️

scientific article published on 19 May 2015

Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

scientific article

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis

scientific article

Fully automated joint space width measurement and digital X-ray radiogrammetry in early RA

scientific article

Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study ⬇️

scientific article published on August 1, 2012

Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort

scientific article published on 18 January 2018

Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assesso

scientific article

Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study

scientific article published on 11 November 2016

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study

scientific article

Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre study

scientific article published on 29 January 2014

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

scientific article

How to dose infliximab in rheumatoid arthritis: new data on a serious issue

scientific article published in August 2009

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

scientific article

Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort

scientific article

In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial ⬇️

scientific article published on September 19, 2011

Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study

scientific article

Incorrect Values for Intractable and Cluster Headaches at Enrollment Shown in Figure 1 and Incorrect Prevalence of Headache at Ten Years in Text of the Article by Hanly et al (Arthritis Rheum, November 2013)

scholarly article by John G. Hanly et al published 27 May 2014 in Arthritis & Rheumatology

Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus

scientific article published on April 2001

Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials

scientific article published on 06 September 2016

Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study

scientific article

Integrated safety in tocilizumab clinical trials

scientific article published in September 2011

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

scientific article

Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis

scientific article published on 15 April 2009

Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial

scientific article published on 18 January 2008

Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients

scientific article

Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response ⬇️

scientific article published on January 3, 2013

Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial

scientific article

Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension

scientific article

Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients

scientific article

Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years

scientific article published on 15 August 2015

Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort

scientific article published on 20 December 2018

Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis

scientific article

Lupus Science and Medicine: the Editors present highlights for the bedside and for the bench in the inaugural issue

scientific article published on 2 April 2014

Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus

scientific article published on 25 November 2019

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

scientific article published on September 2011

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab

scientific article published on 10 May 2016

Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis

scientific article

Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

scientific article published on July 2015

Moving towards a molecular taxonomy of autoimmune rheumatic diseases

scientific article published in January 2018

Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach

scientific article published on 08 January 2020

New and future agents in the treatment of rheumatoid arthritis.

scientific article

New drugs in systemic lupus erythematosus: when to start and when to stop

scientific article published on July 2013

Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study

scientific article published on 22 December 2017

Novel targeted therapies: the future of rheumatoid arthritis? Mavrilumab and tabalumab as examples ⬇️

scientific article published on April 26, 2013

Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial

scientific article published on 9 August 2017

Observational studies: a valuable source for data on the true value of RA therapies ⬇️

scientific article published on December 22, 2010

Off-label use of rituximab for systemic lupus erythematosus in Europe

scientific article

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

scientific article

Patient Preference Assessment Reveals Disease Aspects Not Covered by Recommended Outcomes in Polymyositis and Dermatomyositis ⬇️

scientific article published on April 12, 2011

Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment

scientific article published on 18 September 2017

Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis

scholarly article by Thierry Dervieux et al published January 2012 in Pharmacogenetics and Genomics

Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study

scientific article published on 28 November 2019

Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging stu

scientific article published on May 1, 2012

Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index

scientific article published on 12 February 2020

Prediction of hospitalizations in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI)

scientific article published on 05 November 2020

Predictors of persistent disease activity and long quiescence in systemic lupus erythematosus: results from the Hopkins Lupus Cohort

scholarly article by Ioanna Giannakou et al published 2018 in Lupus science & medicine

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial

scientific article published on 8 May 2014

Prevalence and comorbidity of relapsing polychondritis

scientific article published on 30 September 2016

Psychosis in Systemic Lupus Erythematosus

Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized cont

scientific article

Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.

scientific article

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

scientific article

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

scholarly article by D. Aletaha et al published 15 October 2008 in Arthritis and Rheumatism

Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers ⬇️

scientific article published on 12 August 2016

Response to: 'MBDA: what is it good for?' by Yazici et al.

scientific article published on 28 August 2014

Rheumatoid Arthritis: Treatment [151-201]: 151. Should we be Looking More Carefully for Methotrexate Induced Liver Disease?

scholarly article by M. Lloyd et al published 22 March 2010 in Rheumatology

Rheumatoid arthritis in 2012: Progress in RA genetics, pathology and therapy

scientific article published on 08 January 2013

Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA?

scientific article published on 30 July 2013

Rheumatologists, take heart! We may be doing something right

scientific article published on 7 March 2008

Rituximab - shadow, illusion or light?

scientific article published on 22 October 2011

Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration

scientific article

Rituximab and lupus--a promising pair?

scientific article

Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis

scientific article published on 27 August 2015

Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or Corticosteroids

scientific article published on 24 October 2018

Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices

scientific article published in November 2015

Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open-label extension analysis

article

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis

scientific article published on 15 March 2017

Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme

scientific article published on 28 October 2020

Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study

scientific article

Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial

scientific article published on 01 February 2019

Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial

scientific article published on 30 September 2015

Sex differences in rheumatoid arthritis: more than meets the eye..

scientific article

Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis

scientific article

Small molecular compounds in development for rheumatoid arthritis ⬇️

scientific article published on May 1, 2013

Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus

scientific article published on 17 October 2019

Study of Flare Assessment in Systemic Lupus Erythematosus Based on Paper Patients

scientific article published on 7 April 2017

Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?

scientific article (publication date: 2015)

Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial ⬇️

scientific article published on May 16, 2012

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE ⬇️

scientific article published on October 19, 2011

Swedish registers to examine drug safety and clinical issues in RA.

scientific article published on 13 January 2006

Switching between anti-tumour necrosis factors: trying to get a handle on a complex issue

scientific article published on July 2007

Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis

scientific article published on 23 June 2016

Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor-methotrexate combination therapy versus triple therapy in rheumatoid arthritis

scientific article published on 03 January 2017

Systemic lupus erythematosus.

scientific article published on 16 June 2016

Systemic lupus international collaborating clinics renal activity/response exercise: Comparison of agreement in rating renal response

article

Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index

scientific article published in June 2008

Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions ⬇️

scientific article

Ten years with biologics: to whom do data on effectiveness and safety apply?

scientific article

Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis. ⬇️

scientific article published on 16 November 2017

The association between diet and glucocorticoid treatment in patients with SLE

scientific article published on 27 January 2016

The comparison of trial data-based and registry data-based cost-effectiveness of infliximab treatment for rheumatoid arthritis in Sweden using a modeling approach

scientific article

The effects of an educational meeting and subsequent computer reminders on the ordering of laboratory tests by rheumatologists: an interrupted time series analysis

scientific article published on 23 March 2017

The frequency and outcome of lupus nephritis: results from an international inception cohort study

scientific article published on 05 September 2015

The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region

scientific article

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients

scientific article published on January 2017

The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving st

scientific article

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

scientific article

Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial

scientific article published on 7 April 2017

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial

scientific article published on 28 October 2015

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

scientific article published on 18 March 2013

Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis

scientific article published on 29 February 2016

Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis

scientific article

Treat-to-target in systemic lupus erythematosus: Where are we?

scientific article published on 01 February 2020

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force ⬇️

scientific article published on 12 May 2015

Treatment Algorithms in Systemic Lupus Erythematosus

scientific article

Treatment of rheumatoid arthritis: state of the art 2009.

scientific article published on October 2009

Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense

scientific article

Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.

scientific article published on 13 October 2006

Twenty-eight-week results from the REALISTIC phase IIIb randomized trial: efficacy, safety and predictability of response to certolizumab pegol in a diverse rheumatoid arthritis population ⬇️

scientific article

Unresolved issues in biologic therapy for rheumatoid arthritis ⬇️

scientific article published on 08 March 2011

Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials

scientific article

Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen

scientific article published on 01 July 2019

VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype

scientific article

VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis

scientific article published on 16 October 2015

Paulina is supported by:

About Paulina

Help